Zepp Health Corporation ZEPP

New Research Report on ZEPP

[cmarketinsights]

Fundamental Research released a new research report on Zepp Health Corporation (NYSE: ZEPP), a lesser-known contender in the consumer electronics and smartwatch arena. In Q4-2024, Zepp saw a striking 40% QoQ revenue surge, fueled by a 29% rise in shipments, largely from its rugged T-Rex 3 smartwatch. Despite a global smartwatch shipment drop of 7% YoY in 2024, Zepp holds steady as the seventh-largest player worldwide, trailing giants like Apple and Samsung. New U.S. tariffs on Chinese imports could boost its South Asia-produced affordable wearables, particularly in North America, which accounts for 25% of its shipments. Notably, its working capital and investments (net of debt) total $207M, far exceeding its $51M market cap. The report also forecasts a 2% uptick in smartwatch shipments industry-wide in 2025, driven by health trends and AI integration

 

click hereRead the full report: 

 

 

Disclaimer: This article and research coverage is paid for and commissioned by issuers.